Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas

Annals of Surgical Oncology

Volumn 19, Issue 3, 2012, Pages 1024-1033

  Murali, Rajmohan ^a,b,c,f   Goumas, Chris ^d   Kricker, Anne ^b,d   From, Lynn ^e   Busam, Klaus J ^f   Begg, Colin B ^f   Dwyer, Terence ^g   Gruber, Stephen B ^h   Kanetsky, Peter A ⁱ   Orlow, Irene ^f   Rosso, Stefano ^j   Thomas, Nancy E ^k   Berwick, Marianne ^l   Scolyer, Richard A ^a,b,c   Armstrong, Bruce K ^b,d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j CPO Registro Tumori Piemonte   (Italy)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CASE CONTROL STUDY; CLINICAL FEATURE; DYSPLASTIC NEVUS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIMARY TUMOR; SECOND CANCER; STATISTICAL ANALYSIS; TUMOR LOCALIZATION; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE CANCER; NEVUS; PATHOLOGY; SKIN TUMOR;

AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEVUS; SKIN NEOPLASMS;

EID: 84862259397     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2058-8     Document Type: Article

References (54)

1. Savoia P, Quaglino P, Verrone A, et al. Multiple primary melanomas: analysis of 49 cases. Melanoma Res. 1998;8(4):361-6. (Pubitemid 28442568)
2. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647-54. (Pubitemid 41407357)
3. Uliasz A, Lebwohl M. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol. 2007;46(6):575-7. (Pubitemid 46909397)
4. Burden AD, Newell J, Andrew N, et al. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135(3):261-5. (Pubitemid 29159207)
5. Burden AD, Vestey JP, Sirel JM, et al. Multiple primary melanoma: risk factors and prognostic implications. BMJ. 1994;309(6951):375.
6. Lucchina LC, Barnhill RL, Duke DM, et al. Familial cutaneous melanoma. Melanoma Res. 1995;5(6):413-8.
7. Gupta BK, Piedmonte MR, Karakousis CP. Attributes and survival patterns of multiple primary cutaneous malignant melanoma. Cancer. 1991;67(7):1984-9.
8. Moseley HS, Giuliano AE, Storm FK, 3rd, et al. Multiple primary melanoma. Cancer. 1979;43(3):939-44. (Pubitemid 9163623)
9. Slingluff CL Jr, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993;113(3):330-9. (Pubitemid 23082254)
10. Kang S, Barnhill RL, Mihm MC, Jr., et al. Multiple primary cutaneous melanomas. Cancer. 1992;70(7):1911-6.
11. Reimer RR, Clark WH Jr, Greene MH, et al. Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA. 1978;239(8):744-6. (Pubitemid 8276472)
12. Frank W, Rogers GS. Melanoma update. Second primary melanoma. J Dermatol Surg Oncol. 1993;19(5):427-30.
13. Pack GT, Scharnagel IM, Hillyer RA. Multiple primary melanoma. Cancer. 1952;5(6):1110-5.
14. Beardmore GL, Davis NC. Multiple primary cutaneous melanomas. Arch Dermatol. 1975;111(5):603-9.
15. Cascinelli N, Fontana V, Cataldo I, et al. Multiple primary melanoma. Tumori. 1975;61(5):481-6.
16. Scheibner A, Milton GW, McCarthy WH, et al. Multiple primary melanoma-a review of 90 cases. Australas J Dermatol. 1982;23(1):1-8. (Pubitemid 13248790)
17. Titus-Ernstoff L, Duray PH, Ernstoff MS, et al. Dysplastic nevi in association with multiple primary melanoma. Cancer Res. 1988;48(4):1016-8. (Pubitemid 18061904)
18. Ariyan S, Poo WJ, Bolognia J, et al. Multiple primary melanomas: data and significance. Plast Reconstr Surg. 1995;96(6):1384-9.
19. Giles G, Staples M, McCredie M, et al. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5(6):433-8.
20. Marghoob AA, Slade J, Kopf AW, et al. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study. Br J Dermatol. 1996;135(5):704-11. (Pubitemid 26375885)
21. Brobeil A, Rapaport D, Wells K, et al. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997;4(1):19-23.
22. Johnson TM, Hamilton T, Lowe L. Multiple primary melanomas. J Am Acad Dermatol. 1998;39(3):422-7. (Pubitemid 28417378)
23. Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;338(13):879-87. (Pubitemid 28135965)
24. Bhatia S, Estrada-Batres L, Maryon T, et al. Second primary tumors in patients with cutaneous malignant melanoma. Cancer. 1999;86(10):2014-20.
25. DiFronzo LA, Wanek LA, Elashoff R, et al. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol. 1999;6(7):705-11.
26. Wolff J, Wollina U. Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol. 2000;14(6):479-83. (Pubitemid 32899271)
27. DiFronzo LA, Wanek LA, Morton DL. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer. 2001;91(8):1520-4. (Pubitemid 32319263)
28. Schmid-Wendtner MH, Baumert J, Wendtner CM, et al. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol. 2001;145(6):981-5. (Pubitemid 34204474)
29. Stam-Posthuma JJ, van Duinen C, Scheffer E, et al. Multiple primary melanomas. J Am Acad Dermatol. 2001;44(1):22-7. (Pubitemid 32110558)
30. Blackwood MA, Holmes R, Synnestvedt M, et al. Multiple primary melanoma revisited. Cancer. 2002;94(8):2248-55. (Pubitemid 34411984)
31. Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003;139(8):1013-8. (Pubitemid 36994826)
32. Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer. 2003;97(3):639-43. (Pubitemid 36125840)
33. Titus-Ernstoff L, Perry AE, Spencer SK, et al. Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol. 2006;142(4):433-8. (Pubitemid 43671641)
34. Bower MR, Scoggins CR, Martin RC 2nd, et al. Second primary melanomas: incidence and outcome. American Surgeon. 2010;76(7):675-81.
35. Begg CB, Hummer AJ, Mujumdar U, et al. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006;35(3):756-64. (Pubitemid 43985574)
36. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
37. Guerriere-Kovach PM, Hunt EL, Patterson JW, et al. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes. Am J Clin Pathol. 2004;122(1):70-7. (Pubitemid 38849874)
38. Orlow I, Tommasi DV, Bloom B, et al. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. J Invest Dermatol. 2009;129(8):1972-82.
39. Manganoni AM, Farisoglio C, Tucci G, et al. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases. J Eur Acad Dermatol Venereol. 2007;21(10):1333-6. (Pubitemid 350020139)
40. Allen AC, Spitz S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6(1):1-45.
41. Rigel DS, Friedman RJ, Kopf AW, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol. 1986;14(5 Pt 1):857-60.
42. Carli P, De Giorgi V, Chiarugi A, et al. Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol. 2002;41(9):583-5. (Pubitemid 35174075)
43. Poo-Hwu WJ, Ariyan S, Lamb L, et al. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer. 1999;86(11):2252-8. (Pubitemid 30010365)
44. Green A, MacLennan R, Youl P, et al. Site distribution of cutaneous melanoma in Queensland. Int J Cancer. 1993;53(2):232-6. (Pubitemid 23042871)
45. Whiteman DC, Bray CA, Siskind V, et al. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001. Cancer Causes Control. 2007;18(5):485-91. (Pubitemid 46684821)
46. Kricker A, Armstrong BK, Goumas C, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control. 2007;18(3):295-304. (Pubitemid 46356209)
47. Duncan LM. The classification of cutaneous melanoma. Hematol Oncol Clin North Am. 2009;23(3):501-13, ix.
48. Balch CM, Wilkerson JA, Murad TM, et al. The prognostic significance of ulceration of cutaneous melanoma. Cancer. 1980;45(12):3012-7. (Pubitemid 11191749)
49. Lock-Andersen J, Hou-Jensen K, Hansen JP, et al. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg. 1995;29(2):141-8.
50. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14(4):1218-23. (Pubitemid 26105529)
51. Crutcher WA, Sagebiel RW. Prevalence of dysplastic naevi in a community practice. Lancet. 1984;1(8379):729.
52. Greene MH, Clark WH Jr, Tucker MA, et al. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985;102(4):458-65. (Pubitemid 15109001)
53. Tucker MA, Fraser MC, Goldstein AM, et al. Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol. 1993;100(3):350S-5S. (Pubitemid 23083198)
54. Carey WP, Jr., Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994;74(12):3118-25. (Pubitemid 24375068)